共 50 条
Attitudes and opinions of pregnant women who are not offered cystic fibrosis carrier screening
被引:0
|作者:
Liane Ioannou
John Massie
Sharon Lewis
Veronica Collins
Belinda McClaren
Martin B Delatycki
机构:
[1] Bruce Lefroy Centre for Genetic Health Research,Department of Medicine
[2] Murdoch Childrens Research Institute,Department of Respiratory Medicine
[3] Monash University,Department of Paediatrics
[4] Royal Children’s Hospital,undefined
[5] University of Melbourne,undefined
[6] Andrology Australia,undefined
[7] Monash Institute of Medical Research,undefined
[8] Clinical Genetics,undefined
[9] Austin Health,undefined
来源:
关键词:
genetic screening;
cystic fibrosis;
cystic fibrosis carrier screening;
attitudes;
D O I:
暂无
中图分类号:
学科分类号:
摘要:
Cystic fibrosis (CF) is the most common severe, autosomal recessive disease among Caucasians. A population-based CF carrier screening programme was implemented in Victoria, Australia, in 2006. Carrier screening for CF is currently only offered in the private health system. The aim of this study was to determine the attitudes and opinions of pregnant women in the public health system, towards screening for CF. Pregnant women were recruited in the antenatal clinics of two public hospitals, and invited to participate in the study. Results of this study were compared with previous studies where screening for CF carrier status was offered. Of the participants (n=158), the majority were aged 25–34 years old (66.1%) and were Caucasian (45.8%). Compared with those who were offered screening (reported in previous studies) participants in the current study were younger, had a lower level of education and a lower income. Knowledge was significantly lower in those who were not offered screening compared with those who were offered screening. The majority of participants believe CF carrier screening should be offered in the public health system (80.5%) and almost half would have liked to receive an offer of screening during their current pregnancy (49.7%). In order for the programme to be equitable, screening for CF carrier status needs to be offered in both the public and private health system and ideally should be at no cost to the user.
引用
收藏
页码:859 / 865
页数:6
相关论文